American Well Corp Files Q3 2024 10-Q
Ticker: AMWL · Form: 10-Q · Filed: 2024-10-30T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, telehealth
Related Tickers: AMWL
TL;DR
AMWL Q3 10-Q is in! Check financials for telehealth performance.
AI Summary
American Well Corp (AMWL) filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the third quarter. Key financial metrics and business segment information are presented, reflecting the company's ongoing activities in the telehealth sector.
Why It Matters
This filing provides investors with the latest financial results and operational details for American Well Corp, crucial for understanding the company's performance and future outlook in the evolving telehealth market.
Risk Assessment
Risk Level: medium — The filing contains standard financial disclosures for a public company, but the telehealth sector can be subject to regulatory changes and competitive pressures.
Key Numbers
- 0.1 — Q3 (Represents a financial metric for the third quarter, likely a ratio or percentage.)
- 0.05 — Q3 (Represents a financial metric for the third quarter, likely a ratio or percentage.)
- 0.05 — Q3 (Represents a financial metric for the third quarter, likely a ratio or percentage.)
Key Players & Entities
- American Well Corp (company) — Filer of the 10-Q
- 0000950170-24-119005 (other) — Accession Number for the filing
- 20240930 (date) — Conformed Period of Report
- 20241030 (date) — Filed as of Date
- Boston, MA (location) — Company Headquarters
FAQ
What were American Well Corp's total revenues for the nine months ended September 30, 2024?
The filing indicates financial data for the period January 1, 2024 to September 30, 2024, but specific total revenue figures are not explicitly stated in the provided text snippet.
What is the company's fiscal year end?
The fiscal year end for American Well Corp is December 31.
What is the SIC code for American Well Corp?
The Standard Industrial Classification (SIC) code for American Well Corp is 7389, categorized under SERVICES-BUSINESS SERVICES, NEC.
What is the filing date of this 10-Q report?
This 10-Q report was filed as of October 30, 2024.
Does the filing mention any specific customer concentration risks?
Yes, the filing references 'us-gaap:CustomerConcentrationRiskMember' in relation to 'amwl:RelatedPartyClientOneMember' for the period January 1, 2024 to September 30, 2024.
From the Filing
0000950170-24-119005.txt : 20241030 0000950170-24-119005.hdr.sgml : 20241030 20241030161532 ACCESSION NUMBER: 0000950170-24-119005 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 73 CONFORMED PERIOD OF REPORT: 20240930 FILED AS OF DATE: 20241030 DATE AS OF CHANGE: 20241030 FILER: COMPANY DATA: COMPANY CONFORMED NAME: American Well Corp CENTRAL INDEX KEY: 0001393584 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-39515 FILM NUMBER: 241410539 BUSINESS ADDRESS: STREET 1: 75 STATE STREET STREET 2: 26TH FLOOR CITY: Boston STATE: MA ZIP: 02109 BUSINESS PHONE: 617-205-3500 MAIL ADDRESS: STREET 1: 75 STATE STREET STREET 2: 26TH FLOOR CITY: Boston STATE: MA ZIP: 02109 10-Q 1 amwl-20240930.htm 10-Q 10-Q false 0001393584 --12-31 Q3 0.1 0.05 0.05 1 0001393584 amwl:VisitsMember 2024-01-01 2024-09-30 0001393584 2023-12-31 0001393584 us-gaap:CommonClassBMember 2023-12-31 0001393584 amwl:CcawJvLlcMember 2024-07-01 2024-09-30 0001393584 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001393584 srt:MaximumMember 2024-01-01 2024-09-30 0001393584 us-gaap:ResearchAndDevelopmentExpenseMember 2024-07-01 2024-09-30 0001393584 us-gaap:RestrictedStockMember srt:MaximumMember 2024-01-01 2024-09-30 0001393584 amwl:PlatformSubscriptionMember 2024-01-01 2024-09-30 0001393584 us-gaap:SellingAndMarketingExpenseMember 2023-01-01 2023-09-30 0001393584 us-gaap:PerformanceSharesMember 2024-01-01 2024-09-30 0001393584 us-gaap:RetainedEarningsAppropriatedMember 2024-09-30 0001393584 us-gaap:RestrictedStockMember srt:MinimumMember 2024-01-01 2024-09-30 0001393584 us-gaap:RetainedEarningsAppropriatedMember 2023-12-31 0001393584 us-gaap:SalesRevenueNetMember amwl:RelatedPartyClientOneMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-09-30 0001393584 us-gaap:ParentMember 2024-01-01 2024-03-31 0001393584 us-gaap:RelatedPartyMember 2024-07-01 2024-09-30 0001393584 us-gaap:RelatedPartyMember 2023-07-01 2023-09-30 0001393584 us-gaap:CommonStockMember 2024-06-30 0001393584 2024-01-01 2024-09-30 0001393584 us-gaap:RetainedEarningsAppropriatedMember 2024-07-01 2024-09-30 0001393584 us-gaap:CommonStockMember 2023-09-30 0001393584 amwl:NtnMemberMember us-gaap:NoncontrollingInterestMember 2024-09-30 0001393584 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001393584 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-30 0001393584 amwl:CcawJvLlcMember 2023-01-01 2023-09-30 0001393584 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001393584 srt:MinimumMember 2024-06-18 2024-06-18 0001393584 amwl:CcacvJvLlcMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2024-07-01 2024-09-30 0001393584 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2024-09-30 0001393584 us-gaap:ParentMember 2023-06-30 0001393584 2023-01-01 2023-12-31 0001393584 amwl:NtnMemberMember 2023-07-01 2023-09-30 0001393584 us-gaap:RelatedPartyMember 2024-01-01 2024-09-30 0001393584 us-gaap:RetainedEarningsAppropriatedMember 2024-06-30 0001393584 amwl:TwoThousandAndTwentyEquityIncentivePlanMember 2024-01-01 2024-09-30 0001393584 amwl:VisitsMember 2024-07-01 2024-09-30 0001393584 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001393584 amwl:UnvestedPerformanceMarketBasedStockUnitsMember 2023-07-01 2023-09-30 0001393584 amwl:CcacvJvLlcMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2024-09-30 0001393584 amwl:NtnMemberMember 2023-01-01 2023-09-30 0001393584 amwl:ClevelandClinicMember 2023-12-31 0001393584 amwl:NtnMemberMember 2024-07-01 2024-09-30 0001393584 amwl:UnvestedRestrictedStockMember 2023-07-01 2023-09-30 0001393584 us-gaap:GeneralAndAdministrativeExpenseMember 2024-07-01 2024-09-30 0001393584 us-gaap:CommonClassBMember 2024-10-18 0001393584 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2023-07-01 20